Nathan Bryson

Nathan Bryson is a highly accomplished chemist with extensive experience in the pharmaceutical and life sciences industry. He holds a PhD in Chemistry, with a specialization in Radiopharmaceuticals from the Massachusetts Institute of Technology. He has also studied NATO Post-doctoral Fellow in Organometallic synthesis at University of Strasbourg and Post-doctorate in Polymers at Massachusetts Institute of Technology. Prior to his academic pursuits, he earned his BSc in Chemistry from Auburn University.

Bryson has held several key positions throughout his career, including Chief Scientific Officer at Field Trip Health, Acerus Pharma, Cynapsus Therapeutics, and Cannasat Therapeutics. He has also worked as a Product Development Consultant at NB Consulting, Vice President of Research & Development at Matregen, Executive Director of Research at Bionisis, and Senior Chemist and Scientific Animator at Flamel Technologies.

In his role as a Chief Scientific Officer, Bryson has been instrumental in developing and executing research and development strategies, overseeing clinical trials, and managing cross-functional teams. He is an expert in drug delivery and has extensive experience in developing new drug formulations and delivery mechanisms.

Overall, Nathan Bryson is a highly respected chemist and pharmaceutical industry professional with a proven track record of success. He is passionate about advancing the field of drug delivery and has a keen interest in clinical development and research.